These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 37128947)

  • 1. Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies.
    Graciaa DS; Schechter MC; Fetalvero KB; Cranmer LM; Kempker RR; Castro KG
    Expert Rev Anti Infect Ther; 2023 Jun; 21(6):595-616. PubMed ID: 37128947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment.
    Seddon JA; Johnson S; Palmer M; van der Zalm MM; Lopez-Varela E; Hughes J; Schaaf HS
    Expert Rev Respir Med; 2021 Feb; 15(2):221-237. PubMed ID: 32965141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future treatments for tuberculosis.
    Lee A; Xie YL; Barry CE; Chen RY
    BMJ; 2020 Mar; 368():m216. PubMed ID: 32122882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Global Landscape of Tuberculosis Therapeutics.
    Tornheim JA; Dooley KE
    Annu Rev Med; 2019 Jan; 70():105-120. PubMed ID: 30403551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cursed duet today: Tuberculosis and HIV-coinfection.
    Tiberi S; Carvalho AC; Sulis G; Vaghela D; Rendon A; Mello FC; Rahman A; Matin N; Zumla A; Pontali E
    Presse Med; 2017 Mar; 46(2 Pt 2):e23-e39. PubMed ID: 28256380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic revolution: Transforming tuberculosis diagnosis and treatment with the use of Whole Genome Sequencing - A consensus statement.
    Arora VK; Jindal SK; Katiyar SK; Behra D; Talwar D; Sarin R; Dhar R; Mehta P; Bhargava S; Singhal P; Joshi S; Tiwaskar M; Nikam C; Chatterjee A; Vora A
    Indian J Tuberc; 2023 Oct; 70(4):383-389. PubMed ID: 37968042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary tuberculosis: Improving diagnosis and management.
    Singer-Leshinsky S
    JAAPA; 2016 Feb; 29(2):20-5. PubMed ID: 26757063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.
    Marks SM; Mase SR; Morris SB
    Clin Infect Dis; 2017 Jun; 64(12):1670-1677. PubMed ID: 28329197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New and rediscovered treatments for tuberculosis].
    Kraef C; Lillebæk T; Andersen ÅB; Kirk O
    Ugeskr Laeger; 2022 Mar; 184(10):. PubMed ID: 35315752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer Drugs for Tuberculosis Prevention and Treatment in Children.
    Marais BJ
    Indian J Pediatr; 2019 Aug; 86(8):725-731. PubMed ID: 30707347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of tuberculosis infection in children.
    Hatzenbuehler LA; Starke JR
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):695-708. PubMed ID: 30132364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis.
    Parums DV
    Med Sci Monit; 2021 Aug; 27():e934292. PubMed ID: 34366429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric drug-resistant tuberculosis: a global perspective: a global perspective.
    Reubenson G
    Paediatr Drugs; 2011 Dec; 13(6):349-55. PubMed ID: 21999648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The paradigm shift to end tuberculosis. Are we ready to assume the changes?
    Monedero I; Bhavaraju R; Mendoza-Ticona A; Sánchez-Montalvá A
    Expert Rev Respir Med; 2017 Jul; 11(7):565-579. PubMed ID: 28562103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of drug resistantTB in patients with HIV co-infection.
    Pontali E; Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
    Expert Opin Pharmacother; 2015; 16(18):2737-50. PubMed ID: 26478945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis.
    O'Grady J; Maeurer M; Mwaba P; Kapata N; Bates M; Hoelscher M; Zumla A
    Curr Opin Pulm Med; 2011 May; 17(3):134-41. PubMed ID: 21415753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016.
    Campbell JR; Nsengiyumva P; Chiang LY; Jamieson F; Khadawardi H; Mah HK; Oxlade O; Rasberry H; Rea E; Romanowski K; Sabur NF; Sander B; Uppal A; Johnston JC; Schwartzman K; Brode SK
    Emerg Infect Dis; 2022 Sep; 28(9):1814-1823. PubMed ID: 35997366
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.